Anti-Müllerian hormone reflects the severity of polycystic ovary syndrome.

Jacob, S L; Field, H P; Calder, N; Picton, H M; Balen, A H; Barth, J H

Jacob, S L; Field, H P; Calder, N; Picton, H M; Balen, A H; Barth, J H.

Affiliation

Jacob SL; Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds, UK.
Field HP; Blood Sciences, Leeds General Infirmary, Leeds, UK.
Calder N; Blood Sciences, Leeds General Infirmary, Leeds, UK.
Picton HM; Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds, UK.
Balen AH; Leeds Centre for Reproductive Medicine, Seacroft Hospital, Leeds, UK.
Barth JH; Blood Sciences, Leeds General Infirmary, Leeds, UK.

Clin Endocrinol (Oxf) ; 86(3): 395-400, 2017 Mar.

Article in En | MEDLINE | ID: mdl-27805276

Subject(s)

Anti-Mullerian Hormone/blood; Polycystic Ovary Syndrome/diagnosis; Adult; Anovulation/diagnosis; Diagnosis, Differential; Female; Humans; Hyperandrogenism/diagnosis; Polycystic Ovary Syndrome/blood; ROC Curve; Severity of Illness Index; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Polycystic Ovary Syndrome / Anti-Mullerian Hormone Type of study: Diagnostic_studies / Prognostic_studies Limits: Adult / Female / Humans Language: En Journal: Clin Endocrinol (Oxf) Year: 2017 Type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google